コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ing the activity of let-363 (TOR) or daf-15 (RAPTOR).
2 a rapamycin-sensitive complex that involves Raptor.
3 king out rictor or Sin1 but not by silencing raptor.
4 to 43% in two decades of this once-abundant raptor.
5 cross-linking and interaction of 4E-BP1 with Raptor.
6 sult of enhanced interaction of p70S6K1 with raptor.
7 ween the two substrates for interaction with raptor.
8 phorylation site, RPGT908T, for ICK in human Raptor.
9 ines correlate well with theory generated by RAPTOR.
10 iation between mTOR and the mTORC1 co-factor Raptor.
11 b1, AMP-activated protein kinase (AMPK), and raptor.
12 enetic reduction of the mTOR-binding protein Raptor.
13 ey component of the mTOR complex 1 (mTORC1), Raptor.
14 mbly and signaling by folding both mLST8 and Raptor.
15 ORC1 inhibitor rapamycin or by knocking down raptor.
16 nce for genome-wide rapid evolution in these raptors.
17 d environments frequented by hawks and other raptors.
18 assay) and mTOR pathway protein expression (raptor, 4e-bp-1, and p70S6K proteins) along with enhance
19 Mass spectrometric analysis of cross-linked Raptor-4E-BP1 led to the identification of several cross
20 3% (median 19%) improvement as compared with RAPTOR (a well-known threading method) and even a mean 1
21 r stress, ABA-activated SnRK2s phosphorylate Raptor, a component of the TOR complex, triggering TOR c
23 addition, we found that MARK4 phosphorylates Raptor, a key component of mTORC1, and this phosphorylat
24 owth factor-induced nuclear translocation of Raptor, a regulatory scaffolding component in mTORC1, an
25 leton, we conducted morphometric analyses on raptors, a polyphyletic group at the base of the landbir
26 ed serine phosphorylation of RAPTOR in a new Raptor (AA) mouse model, in which AMPK phospho-serine si
31 ic acetyl-CoA levels, which led to decreased Raptor acetylation and reduced lysosomal localization of
32 fects on autophagy are mediated by decreased raptor acetylation causing mTORC1 inhibition, rather tha
33 tutive and inducible deletion of conditional Raptor alleles in renal tubular epithelial cells, we dis
38 of the Hippo pathway, phosphorylate S606 of Raptor, an essential component of mTORC1, to attenuate m
39 ctive mutant displays higher affinity toward Raptor, an essential scaffolding component of mTORC1 tha
40 neage-specific deletion of the gene encoding RAPTOR, an essential signaling adaptor for rapamycin-sen
42 we used live imaging of the mTORC1 component RAPTOR and a cell permeant fluorescent analogue of di-le
43 PK) activation, increased phosphorylation of raptor and acetyl-CoA carboxylase, and decreased phospho
44 n the DDB1-CUL4 ubiquitin ligase complex and raptor and counteracts DDB1-CUL4-mediated raptor ubiquit
45 tly by phosphorylation of the mTORC1 subunit Raptor and indirectly by phosphorylation of the regulato
48 as evidenced by decreased phosphorylation of raptor and mTOR and the downstream targets S6 kinase and
50 S100B calcium-binding protein, mTOR proteins RAPTOR and P70S6, the AMP-kinase catalytic subunit AMPKA
54 SP9X can co-immunoprecipitate mTOR with both Raptor and Rictor, components of mTOR complexes 1 and 2
56 This work used short hairpin RNA against Raptor and Rictor, unique components of mTORC1 and mTORC
58 l diameter was significantly reduced in both Raptor and Tsc1 conditional knockout mice, albeit with v
59 urine liver requires AMPK regulation of both RAPTOR and TSC2 to fully inhibit mTORC1, and this regula
60 a core subunit Raptor, whereas mTORC2 lacks Raptor and, instead, has Rictor and SIN1 as distinct ess
61 ak and the remainder of the skull in diurnal raptors and parrots suggests that integration may be the
62 ds to regulatory-associated protein of mTOR (Raptor) and causes it to translocate to the nucleus upon
63 t of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation
64 ion of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPAR
66 A significant downregulation of p-mTOR, p-Raptor, and p-S6RP was observed, which was restored to n
68 rug insensitive, higher levels of mTOR-bound raptor are detected than in cells where rapamycin stimul
69 ous Caenorhabditis elegans RHEB-1 and DAF-15/Raptor are expressed ubiquitously and localize to lysoso
73 pamycin (mTOR) pathway by phosphorylation of raptor as a transient cell's compensatory mechanism to p
74 (mTOR) functions in two distinct complexes: Raptor-associated mTORC1 and Rictor-associated mTORC2.
78 he subunits of these complexes are mLST8 and Raptor, beta-propeller proteins that stabilize the mTOR
85 malian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery
87 (mTORC1) signaling by conditionally deleting Raptor causes severe defects in iNKT-cell development at
88 ers of NFATc1 and NFATc2 in T cells, such as Raptor, CHEK1, CREB1, RUNX1, SATB1, Ikaros, and Helios.
89 tects the nucleotide state of RagA while the Raptor "claw" threads between the GTPase domains to dete
91 al evidence that ICK interacts with the mTOR/Raptor complex in cells and phosphorylates Raptor in vit
98 blasts or in 293 cells by down-regulation of raptor decreased the levels of the transcription factor
100 with rapamycin recapitulated the effects of RAPTOR deficiency, and both strategies led to the ablati
104 of a transgenic BCR or a BclxL transgene on Raptor-deficient B cells failed to rescue B cell develop
109 ter turnover rate and increased apoptosis of Raptor-deficient LCs, which might additionally affect th
118 via changes in body size, but may also make raptors especially vulnerable when selection pressures a
119 r Thr-908 both in vitro and in vivo and when Raptor exists in protein complexes with or without mTOR.
120 ion systems were used to specifically target Raptor(fl/fl) (mTORC1), either in all tissues upon poly(
122 the early stages of development in Vav-cre(+)Raptor(fl/fl) mice, revealed that these mice do not surv
123 aling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER) mice, which e
125 elper 2 (Th2) cell differentiation, although Raptor function is less important for continuous prolife
126 GDI2 by rictor is not related to the Sin1 or raptor function that excludes a role of mTORC2 or mTORC1
128 pression in Fib-MCs in experiments utilizing raptor gene silencing and overexpression of dominant-inh
129 ile downregulation of mTORC1 activity, using Raptor genetic mouse model or mTORC1 inhibitor treatment
130 ve genomic analysis and comparisons with non-raptor genomes identify common molecular signatures that
132 at the balance of free and mTORC1-associated Raptor governs hepatic lipid accumulation, and uncover t
133 ion of either mTOR or the associated protein Raptor greatly diminishes embryonic skeletal growth asso
134 nd angiogenesis in vivo, whereas the loss of Raptor had only a modest effect on endothelial cells (EC
136 lowing: (i) LARP1 associates with mTORC1 via RAPTOR; (ii) LARP1 interacts with TOP mRNAs in an mTORC1
139 arget of rapamycin (mTOR) or rictor, but not raptor, implicating mTORC2 as the target of rapamycin fo
140 rect AMPK-mediated serine phosphorylation of RAPTOR in a new Raptor (AA) mouse model, in which AMPK p
141 ue-specific deletion of the mTORC1 regulator Raptor in alpha cells (alphaRaptorKO), we showed that mT
142 disruption of the mTOR coactivating protein Raptor in developing mouse B cells resulted in a develop
144 sgenic mice, PRAS40(T246A) remained bound to raptor in keratinocytes even after treatment with TPA, c
145 EAT repeats of Tor2 that are engaged by Kog1/Raptor in mammalian TORC1, explaining the mutual exclusi
152 , conditional depletion of endogenous DAF-15/Raptor in the soma revealed that TORC1 is required at ea
156 n the regulatory associated protein of mTOR (Raptor) in microglia, whose mTORC1 signaling was blocked
157 nent, regulatory-associated protein of mTOR (Raptor), in mouse HSCs and its loss causes a nonlethal p
159 rget of rapamycin complex 1 (mTORC1) subunit Raptor induces cell growth and is a downstream target of
162 TORC1 before complete disruption of the mTOR-raptor interaction, whereas mTORC2 stoichiometry is unaf
165 , our study reveals that enterocyte specific Raptor is required for initiating a type 2 immune respon
166 n (in particular residues from 89 to 180) of Raptor is the major site of interaction with 4E-BP1.
167 athway, in that mTORC1 (with adaptor protein Raptor) is the main complex mediating the maturation and
168 mplex 1 (mTORC1), defined by the presence of Raptor, is an evolutionarily conserved and nutrient-sens
169 h was also observed in rictor mutants, while raptor knockdown did not phenocopy the TSC mutant phenot
170 this signaling pathway with mTOR inhibitors, raptor knockdown or p70S6K inhibitors elevated PD-L1 lev
174 eated skeletal muscle specific and inducible raptor knockout mice to eliminate signaling by mTORC1, a
175 fference in tumor growth between conditional Raptor KO and control mice in the s.c. tumor models, alt
176 tumor microenvironment of mTORC1 conditional Raptor KO mice due to downregulated CD115 expression on
178 4/80(high)) were accumulated in the lungs of Raptor KO mice in the LLC lung metastasis model, leading
179 ipocyte-specific mTOR KO, adipocyte-specific Raptor KO, and adipocyte-specific tuberous sclerosis com
180 specific deletion of the essential component raptor leads to a profound loss of T(reg)-cell suppressi
181 1 activity in DCs by conditional deletion of Raptor leads to a progressive loss of LCs in the skin of
184 with age and in obesity; restoration of free Raptor levels reduces liver triglyceride content, throug
185 se mTORC1 signaling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER)
186 to high-resolution vision in birds, and that raptors may in fact possess high-resolution tetrachromat
187 ulatory associated protein of mTOR-mediated (RAPTOR-mediated) suppression, and altered kinase kinetic
191 tently, knockdown of rictor or mTOR, but not raptor, mimicked PP242 in decreasing FLIP(S) levels and
192 nd survival through forming 2 complexes with raptor (mTOR complex 1; mTORC1) or rictor (mTOR complex
193 inhibited phosphorylation of ribosomal S6, a raptor/mTOR complex 1 (mTORC1) target, without a compens
198 d unaltered ability to express CCR9, whereas Raptor (mTORC1)-deficient Treg were unable to upregulate
203 Using mice with T-cell-specific ablation of Raptor/mTORC1 or Rictor/mTORC2, we revealed that both mT
205 e peptides revealed that the most N-terminal Raptor N-terminal conserved domain (in particular residu
207 e we report that mTORC1-independent ('free') Raptor negatively regulates hepatic Akt activity and lip
208 d not inhibit the association of mTORC1 with Raptor nor did it affect AMP-activated protein kinase ac
210 ically, PKA directly phosphorylated mTOR and RAPTOR on unique serine residues, an effect that was ind
211 st the presence of two structured regions of Raptor: one in the N-terminal region and the other in th
212 acological or genetic inhibition of mTOR and Raptor or expression of a hypophosphorylated mutant vers
213 ither through adipocyte-specific deletion of Raptor or pharmacologic rapamycin treatment, were refrac
216 sed mice with conditional deletion of either Raptor or Rictor genes to determine potential contributi
218 myelination, we conditionally ablated either Raptor or Rictor in the oligodendrocyte lineage, in vivo
220 iting mTOR, depleting its regulatory subunit raptor, or inducing hypoxia all trigger reactivation.
221 n rates (i.e., rates of predation by snakes, raptors, or mesocarnivores) did not differ among male bo
228 n blood tissue between nocturnal and diurnal raptors, possibly indicating adaptive expression change
230 monstrate that ectopic expression of TOR and Raptor (regulatory-associated protein of mTOR), a protei
235 Cells with Nlk deletion or knock-in of the Raptor S863 phosphorylation mutants are defective in the
236 tified in vitro, we found that TBK1 promotes Raptor Ser877 phosphorylation in cells both basally and
242 systemic administration of the 4-1BB aptamer-raptor siRNA to mice downregulated mTORC1 activity in th
243 d with rapamycin, but not with 4-1BB aptamer-raptor siRNA, failed to reject a subsequent tumor challe
245 polyethylene glycol that was formulated with Raptor-small interfering RNA plus spironolactone in vivo
246 present separately in 5 additional fowl and raptor species, all of which are native to areas of Asia
247 istochemistry to evaluate this claim in five raptor species: the common buzzard (Buteo buteo), the ho
248 location to the lysosomal surface, where its Raptor subunit interacts with the Rag guanosine triphosp
249 hows the details of RagA/RagC binding to the RAPTOR subunit of mTORC1 and explains why only the RagA(
250 d in part by the Rag GTPases, which bind the raptor subunit of mTORC1 in an amino acid-stimulated man
251 It contains the atypical kinase mTOR and the RAPTOR subunit that binds to the Tor signalling sequence
258 osteronism expressed increased levels of the Raptor target, p70S6K, which provided a basis for invest
259 roportionately preyed on large females while raptors targeted small females, but female body mass was
261 rthermore, we show that the scaffold protein raptor, that typically recruits mTOR substrates, is not
262 ry associated protein of the MTOR complex 1 (RAPTOR), the serine/threonine kinase V-Akt murine thymom
264 ze and questions: movements of an endangered raptor, the snail kite (Rostrhamus sociabilis plumbeus),
265 ctivity of mTORC1 through phosphorylation of Raptor Thr-908 and thus implicate a potential signaling
267 a phospho-specific antibody, we showed that Raptor Thr-908 is a novel in vivo phosphorylation site.
268 and movement of the key TORC1 component Kog1/Raptor to a single body near the edge of the vacuole.
269 rone (10(-9) to 10(-7) M) increased Akt/mTOR/Raptor to activate p70S6K and increase proliferation, vi
270 ated an siRNA targeting the mTORC1 component raptor to an aptamer that binds 4-1BB, a costimulatory m
271 tabilizes the interaction between PRAS40 and Raptor to inactive mTORC1-mediated hyper-glycolytic meta
273 ing component in mTORC1, and localization of Raptor to the nucleus results in nuclear mTORC1 activity
274 he use of rapid protein threading predictor (RAPTOR) to generate tertiary structures of closely relat
275 n one of the mTOR effector complex proteins, Raptor, to elucidate the role of mTORC1 in leukemia.
276 Here, we inactivate the core component, Raptor, to show that mTORC1 function is critical for mal
277 mutants lacking LST8, expression of TOR and RAPTOR, together with their upstream activator Rheb, was
278 genetic knockout of the major mTOR cofactors raptor (TOR complex 1 [TORC1]) and rictor (TORC2), we no
279 knockout of the major mTOR complex cofactors raptor (TORC1) and rictor (TORC2), we now show that TORC
281 and are no longer able to recruit RACK1 and Raptor, two TRAPP-interactive signaling proteins, sensit
284 atches propagate direct (high and low threat raptor vocalizations) or indirect (high and low threat c
285 ro Optimal inhibition of pulmonary arteriole Raptor was achieved by treatment with Staramine-monometh
286 the effect AMPK activation if either mTOR or Raptor was suppressed, indicating that the inhibitory ef
288 sing mice with T cell-restricted deletion of Raptor, we show that mTORC1 is selectively required for
289 On 4E-BP1, we found that cross-links with Raptor were clustered in the central region (amino acid
291 mTOR by enhancing PRAS40's association with RAPTOR, whereas AICAR blocked the cell cycle through pro
292 plex 1 (mTORC1) is defined by a core subunit Raptor, whereas mTORC2 lacks Raptor and, instead, has Ri
294 ) family members with the TORC1 subunit Kog1/Raptor, which in turn allow the TORC1 proximal kinase Sc
295 including mammalian target of rapamycin and raptor, which resulted in a stimulation of endothelial a
297 termine the structure of the supercomplex of Raptor with Rag-Ragulator at a resolution of 3.2 angstro